A real-world study of the first use of palbociclib for the treatment of advanced breast cancer within the UK National Health Service as part of the novel Ibrance® Patient Program.
Carlo PalmieriAlison MussonCatherine Harper-WynneDuncan WheatleyGianfilippo BertelliIain R J MacphersonMark NathanEllie McDowallAjay BhojwaniMark VerrillJoe EvaColm DoodyRuhe ChowdhuryPublished in: British journal of cancer (2023)
Clinical trial: ClinicalTrial.gov:NCT03921866.